A stabilizing reagent prevents cell-free DNA contamination by cellular DNA in plasma during blood sample storage and shipping as determined by digital PCR

S. E. Norton, J. M. Lechner, T. Williams, M. R. Fernando

Research output: Contribution to journalArticle

95 Citations (Scopus)

Abstract

Objectives: To study the ability of a stabilizing reagent to prevent cellular DNA contamination of cell-free DNA (cfDNA) in plasma during whole blood sample storage and shipping. Design and methods: Samples were drawn from healthy donors into K3EDTA and Cell-Free DNA BCTs (BCT) and stored at room temperature (RT). Aliquots were removed at specified time points and cfDNA was purified from the plasma. A Droplet Digital PCR (ddPCR) assay that amplifies a short β-actin gene fragment (136bp) was used to measure the total plasma cfDNA (pDNA) concentration while a longer β-actin fragment (420bp) was used to quantify genomic DNA (gDNA). In a follow-up experiment, blood samples drawn into the same types of tubes were shipped round trip by overnight air before cfDNA was isolated and analyzed. Results: Blood stored in K3EDTA tubes at RT showed increases in pDNA and gDNA concentrations over time. However, both pDNA and gDNA levels remained stable in BCT for at least seven days. On day 14, there was a 4.5-fold increase in pDNA in BCT as compared to >200-fold increase in K3EDTA tubes. Likewise, gDNA increased <2-fold on day 14 in BCT as opposed to a 456-fold increase in K3EDTA tubes. Similar results were observed after samples were shipped. Conclusions: Cell-Free DNA BCTs prevent gDNA contamination that may occur due to nucleated cell disruption during sample storage and shipping. This novel blood collection tube provides a method for obtaining stable cfDNA samples for rare target detection and accurate analysis while mitigating the threat of gDNA contamination.

Original languageEnglish (US)
Pages (from-to)1561-1565
Number of pages5
JournalClinical Biochemistry
Volume46
Issue number15
DOIs
StatePublished - Oct 1 2013

Fingerprint

DNA Contamination
Freight transportation
Contamination
Blood
Plasmas
Polymerase Chain Reaction
DNA
Actins
Temperature
Plasma Cells

Keywords

  • Blood specimen collection
  • Clinical laboratory techniques
  • DNA contamination
  • DNA in plasma
  • Investigative techniques

ASJC Scopus subject areas

  • Clinical Biochemistry

Cite this

A stabilizing reagent prevents cell-free DNA contamination by cellular DNA in plasma during blood sample storage and shipping as determined by digital PCR. / Norton, S. E.; Lechner, J. M.; Williams, T.; Fernando, M. R.

In: Clinical Biochemistry, Vol. 46, No. 15, 01.10.2013, p. 1561-1565.

Research output: Contribution to journalArticle

@article{3fbf7a36cc264d84949326f749a15f5c,
title = "A stabilizing reagent prevents cell-free DNA contamination by cellular DNA in plasma during blood sample storage and shipping as determined by digital PCR",
abstract = "Objectives: To study the ability of a stabilizing reagent to prevent cellular DNA contamination of cell-free DNA (cfDNA) in plasma during whole blood sample storage and shipping. Design and methods: Samples were drawn from healthy donors into K3EDTA and Cell-Free DNA BCTs (BCT) and stored at room temperature (RT). Aliquots were removed at specified time points and cfDNA was purified from the plasma. A Droplet Digital PCR (ddPCR) assay that amplifies a short β-actin gene fragment (136bp) was used to measure the total plasma cfDNA (pDNA) concentration while a longer β-actin fragment (420bp) was used to quantify genomic DNA (gDNA). In a follow-up experiment, blood samples drawn into the same types of tubes were shipped round trip by overnight air before cfDNA was isolated and analyzed. Results: Blood stored in K3EDTA tubes at RT showed increases in pDNA and gDNA concentrations over time. However, both pDNA and gDNA levels remained stable in BCT for at least seven days. On day 14, there was a 4.5-fold increase in pDNA in BCT as compared to >200-fold increase in K3EDTA tubes. Likewise, gDNA increased <2-fold on day 14 in BCT as opposed to a 456-fold increase in K3EDTA tubes. Similar results were observed after samples were shipped. Conclusions: Cell-Free DNA BCTs prevent gDNA contamination that may occur due to nucleated cell disruption during sample storage and shipping. This novel blood collection tube provides a method for obtaining stable cfDNA samples for rare target detection and accurate analysis while mitigating the threat of gDNA contamination.",
keywords = "Blood specimen collection, Clinical laboratory techniques, DNA contamination, DNA in plasma, Investigative techniques",
author = "Norton, {S. E.} and Lechner, {J. M.} and T. Williams and Fernando, {M. R.}",
year = "2013",
month = "10",
day = "1",
doi = "10.1016/j.clinbiochem.2013.06.002",
language = "English (US)",
volume = "46",
pages = "1561--1565",
journal = "Clinical Biochemistry",
issn = "0009-9120",
publisher = "Elsevier Inc.",
number = "15",

}

TY - JOUR

T1 - A stabilizing reagent prevents cell-free DNA contamination by cellular DNA in plasma during blood sample storage and shipping as determined by digital PCR

AU - Norton, S. E.

AU - Lechner, J. M.

AU - Williams, T.

AU - Fernando, M. R.

PY - 2013/10/1

Y1 - 2013/10/1

N2 - Objectives: To study the ability of a stabilizing reagent to prevent cellular DNA contamination of cell-free DNA (cfDNA) in plasma during whole blood sample storage and shipping. Design and methods: Samples were drawn from healthy donors into K3EDTA and Cell-Free DNA BCTs (BCT) and stored at room temperature (RT). Aliquots were removed at specified time points and cfDNA was purified from the plasma. A Droplet Digital PCR (ddPCR) assay that amplifies a short β-actin gene fragment (136bp) was used to measure the total plasma cfDNA (pDNA) concentration while a longer β-actin fragment (420bp) was used to quantify genomic DNA (gDNA). In a follow-up experiment, blood samples drawn into the same types of tubes were shipped round trip by overnight air before cfDNA was isolated and analyzed. Results: Blood stored in K3EDTA tubes at RT showed increases in pDNA and gDNA concentrations over time. However, both pDNA and gDNA levels remained stable in BCT for at least seven days. On day 14, there was a 4.5-fold increase in pDNA in BCT as compared to >200-fold increase in K3EDTA tubes. Likewise, gDNA increased <2-fold on day 14 in BCT as opposed to a 456-fold increase in K3EDTA tubes. Similar results were observed after samples were shipped. Conclusions: Cell-Free DNA BCTs prevent gDNA contamination that may occur due to nucleated cell disruption during sample storage and shipping. This novel blood collection tube provides a method for obtaining stable cfDNA samples for rare target detection and accurate analysis while mitigating the threat of gDNA contamination.

AB - Objectives: To study the ability of a stabilizing reagent to prevent cellular DNA contamination of cell-free DNA (cfDNA) in plasma during whole blood sample storage and shipping. Design and methods: Samples were drawn from healthy donors into K3EDTA and Cell-Free DNA BCTs (BCT) and stored at room temperature (RT). Aliquots were removed at specified time points and cfDNA was purified from the plasma. A Droplet Digital PCR (ddPCR) assay that amplifies a short β-actin gene fragment (136bp) was used to measure the total plasma cfDNA (pDNA) concentration while a longer β-actin fragment (420bp) was used to quantify genomic DNA (gDNA). In a follow-up experiment, blood samples drawn into the same types of tubes were shipped round trip by overnight air before cfDNA was isolated and analyzed. Results: Blood stored in K3EDTA tubes at RT showed increases in pDNA and gDNA concentrations over time. However, both pDNA and gDNA levels remained stable in BCT for at least seven days. On day 14, there was a 4.5-fold increase in pDNA in BCT as compared to >200-fold increase in K3EDTA tubes. Likewise, gDNA increased <2-fold on day 14 in BCT as opposed to a 456-fold increase in K3EDTA tubes. Similar results were observed after samples were shipped. Conclusions: Cell-Free DNA BCTs prevent gDNA contamination that may occur due to nucleated cell disruption during sample storage and shipping. This novel blood collection tube provides a method for obtaining stable cfDNA samples for rare target detection and accurate analysis while mitigating the threat of gDNA contamination.

KW - Blood specimen collection

KW - Clinical laboratory techniques

KW - DNA contamination

KW - DNA in plasma

KW - Investigative techniques

UR - http://www.scopus.com/inward/record.url?scp=84884350975&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84884350975&partnerID=8YFLogxK

U2 - 10.1016/j.clinbiochem.2013.06.002

DO - 10.1016/j.clinbiochem.2013.06.002

M3 - Article

C2 - 23769817

AN - SCOPUS:84884350975

VL - 46

SP - 1561

EP - 1565

JO - Clinical Biochemistry

JF - Clinical Biochemistry

SN - 0009-9120

IS - 15

ER -